Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of etanercept, and define the toxicity,
when administered to patients with acute non-infectious lung injury (idiopathic pneumonia
syndrome, IPS) and with subacute pulmonary dysfunction after allogeneic stem cell
transplantation.